Molecular Analysis Improves FH Prognosis & Risk Stratification
Physician's Weekly
JUNE 24, 2025
Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy. Rodríguez-Padial and colleagues found that patients with DLCN scores of 6 or higher were younger, experienced less hypertension, and had higher rates of smoking.
Let's personalize your content